How Trenbolone Affects Prolactin
Trenbolone elevates prolactin through progestogenic activity at pituitary lactotroph cells. Elevated prolactin can independently suppress LH, worsen gynecomastia risk, and impair sexual function, making it a critical marker to monitor during and after trenbolone use.
The Mechanism
Trenbolone and its metabolites bind progesterone receptors in pituitary lactotroph cells with significant affinity. Progesterone receptor activation in lactotrophs stimulates prolactin synthesis and secretion. This is independent of the dopaminergic pathway that normally regulates basal prolactin levels, which is why standard dopamine-mediated prolactin control may be overwhelmed during trenbolone use. Elevated prolactin in turn suppresses GnRH pulsatility and LH secretion at the hypothalamic-pituitary level, adding another layer of HPG axis suppression beyond trenbolone's direct androgenic effects.
Expected Changes
Prolactin may rise to 20-40 ng/mL or higher during trenbolone use (normal male range: 2-18 ng/mL). The elevation is dose-dependent and may persist for 2-4 weeks after the last trenbolone acetate injection (half-life approximately 3 days). Higher doses and longer cycles produce more pronounced prolactin elevation. Some individuals are more susceptible to progestin-driven prolactin elevation than others.
Monitoring Guidance
Check prolactin at baseline before starting trenbolone, at mid-cycle (4-6 weeks in), and at the start of PCT. If prolactin remains above 20 ng/mL at the mid-PCT blood draw (after trenbolone has cleared), this may be impairing LH recovery and requires intervention. Recheck prolactin at the post-PCT confirmation draw.
Management Strategies
Cabergoline 0.25-0.5 mg twice weekly is the standard treatment for trenbolone-induced hyperprolactinemia. Start cabergoline if prolactin exceeds 20 ng/mL with symptoms (sexual dysfunction, gynecomastia, low mood) or if it remains elevated during PCT and may be impairing recovery. Avoid overtreatment: prolactin below 2 ng/mL from excessive cabergoline can cause impulse control issues. Taper cabergoline once prolactin normalizes. If prolactin remains elevated 6-8 weeks after the last trenbolone dose and cabergoline fails to normalize it, investigate for prolactinoma (rare but important to exclude).
Further reading: Trenbolone bloodwork: 8 markers to monitor and the red lines to stop
Clinical Significance
Trenbolone-induced prolactin elevation is one of the most impactful secondary effects of 19-nor compounds, capable of independently impairing PCT recovery even after trenbolone itself has cleared.
Frequently Asked Questions
Related Articles
Why Your HRV Is Low on TRT (Normal HRV by Age for Men)
Is an HRV of 25 low on TRT? Normal RMSSD by age for men, why wearables disagree, what testosterone, tren, clen and T3 do, and when low HRV matters.
When Will Orforglipron Be Available in Australia? (TGA Update)
Orforglipron (Foundayo) is not TGA approved yet; the Wegovy Pill is. Realistic Australian timeline, trial results, muscle loss and the bloodwork to run.
Why Your Zone 2 Heart Rate Is Wrong on Clen, T3 and Tren
Clen, T3 and tren push your heart rate up without adding workload, so watch zones lie. How to find your real zone 2, and when resting heart rate is a red flag.
Does Gestrinone Work for Endometriosis? What It Does to Your Labs
Gestrinone eased endometriosis pain in small trials, but it is a 19-nor androgen. What the evidence shows, the Brazilian implant, and the labs to run.
Related Pages
See how this interaction affects your blood work
Upload your blood tests and log your compounds to see personalised interaction data overlaid on your marker trends.
Quick Facts
Effect Direction
Severity
Dose-Dependent
Reversible